GLP-1 drugsHuman trial

Survodutide for the treatment of obesity: Mechanistic rationale, clinical evidence, and remaining uncertainties

Contemporary Clinical Trials

The paper

Consolato M. Sergi

University of Alberta

Contemporary Clinical Trials · 1 Oct 2026

doi.org/10.1016/j.cct.2026.108493 PubMed 42822760

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD
Diabetes, Obesity & Metabolism · 4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Diabetes, Obesity & Metabolism · 4 Oct 2026